The DOI matches its Crossref record; 263 of the 263 references it cites were found in a registry or an index.
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
Open accessAbstract
Cholangiocarcinomas are a heterogeneous group of bile duct cancers and the second most common primary liver tumour worldwide. In this Consensus statement, the newly formed European Network for the Study of Cholangiocarcinoma (ENS-CCA) detail the classification, pathophysiology and underlying mechanisms, and current therapies for cholangiocarcinoma, as well as future perspectives. Cholangiocarcinoma (CCA) is a heterogeneous group of malignancies with features of biliary tract differentiation. CCA is the second most common primary liver tumour and the incidence is increasing worldwide. CCA has high mortality owing to its aggressiveness, late diagnosis and refractory nature. In May 2015, the “European Network for the Study of Cholangiocarcinoma” (ENS-CCA: www.enscca.org or www.cholangiocarcinoma.eu ) was created to promote and boost international research collaboration on the study of CCA at basic, translational and clinical level. In this Consensus Statement, we aim to provide valuable information on classifications, pathological features, risk factors, cells of origin, genetic and epigenetic modifications and current therapies available for this cancer. Moreover, future directions on basic and clinical investigations and plans for the ENS-CCA are highlighted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Edge, S. B., & Compton, C. C. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-010-0985-4 · Cited by 9,029
Acute Abdomen: A Rare Case of Ruptured Hepatocellular Carcinoma
Gloor, S., Jensen, K. O., Breitenstein, S., Binkert, C. A., Angst, E., & Hetzer, F. H. (2017) · Case Reports in Gastroenterology · doi:10.1159/000463378 · Cited by 5,370
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Hanahan, D., & Coussens, L. M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.022 · Cited by 4,632
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
Valle, J., Wasan, H., Palmer, D. H., Cunningham, D., Anthoney, A., Maraveyas, A., Madhusudan, S., Iveson, T., Hughes, S., Pereira, S. P., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908721 · Cited by 4,406
The Global Burden of Cancer 2013
Fitzmaurice, C., Dicker, D., Pain, A., Hamavid, H., Moradi-Lakeh, M., MacIntyre, M. F., Allen, C., Hansen, G., Woodbrook, R., Wolfe, C., et al. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.0735 · Cited by 2,707
Influence of tumour micro-environment heterogeneity on therapeutic response
Junttila, M. R., & de Sauvage, F. J. (2013) · Nature · doi:10.1038/nature12626 · Cited by 2,694
Evolution of the Cancer Stem Cell Model
Kreso, A., & Dick, J. E. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.02.006 · Cited by 2,224
BIOCHEMICAL, CELLULAR, AND PHARMACOLOGICAL ASPECTS OF THE MULTIDRUG TRANSPORTER
Ambudkar, S. V., Dey, S., Hrycyna, C. A., Ramachandra, M., Pastan, I., & Gottesman, M. M. (1999) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.39.1.361 · Cited by 2,059
IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
Turcan, S., Rohle, D., Goenka, A., Walsh, L. A., Fang, F., Yilmaz, E., Campos, C., Fabius, A. W. M., Lu, C., Ward, P. S., et al. (2012) · Nature · doi:10.1038/nature10866 · Cited by 1,974
EASL Clinical Practice Guidelines: management of cholestatic liver diseases
European Association for the Study of the Liver (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.04.009 · Cited by 1,729
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
Bridgewater, J., Galle, P. R., Khan, S. A., Llovet, J. M., Park, J.-W., Patel, T., Pawlik, T. M., & Gores, G. J. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.01.021 · Cited by 1,511
Visvader, J. E. (2011) · Nature · doi:10.1038/nature09781 · Cited by 1,449
Staging, Resectability, and Outcome in 225 Patients With Hilar Cholangiocarcinoma
Jarnagin, W. R., Fong, Y., DeMatteo, R. P., Gonen, M., Burke, E. C., Bodniewicz, J., Youssef, M., Klimstra, D., & Blumgart, L. H. (2001) · Annals of Surgery · doi:10.1097/00000658-200110000-00010 · Cited by 1,347
Pathogenesis, Diagnosis, and Management of Cholangiocarcinoma
Ilyas, S. I., & Gores, G. J. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.10.013 · Cited by 1,307
Genomic spectra of biliary tract cancer
Nakamura, H., Arai, Y., Totoki, Y., Shirota, T., Elzawahry, A., Kato, M., Hama, N., Hosoda, F., Urushidate, T., Ohashi, S., et al. (2015) · Nature Genetics · doi:10.1038/ng.3375 · Cited by 1,284
Diagnosis and Management of Primary Sclerosing Cholangitis
Chapman, R., Fevery, J., Kalloo, A., Nagorney, D. M., Boberg, K. M., Shneider, B., & Gores, G. J. (2010) · Hepatology · doi:10.1002/hep.23294 · Cited by 1,224
Self-citationCholangiocarcinoma: A Spectrum of Intrahepatic, Perihilar, and Distal Tumors
Nakeeb, A., Pitt, H. A., Sohn, T. A., Coleman, J., Abrams, R. A., Piantadosi, S., Hruban, R. H., Lillemoe, K. D., Yeo, C. J., & Cameron, J. L. (1996) · Annals of Surgery · doi:10.1097/00000658-199610000-00005 · Cited by 1,187
Cancer Stem Cells: Impact, Heterogeneity, and Uncertainty
Magee, J. A., Piskounova, E., & Morrison, S. J. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.03.003 · Cited by 1,101
Khan, S. A., Thomas, H. C., Davidson, B. R., & Taylor-Robinson, S. D. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67530-7 · Cited by 1,042
Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update
Khan, S. A., Davidson, B. R., Goldin, R. D., Heaton, N., Karani, J., Pereira, S. P., Rosenberg, W. M. C., Tait, P., Taylor-Robinson, S. D., Thillainayagam, A. V., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-301748 · Cited by 797
Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver.
Bismuth, H., & Corlette, M. B. (1975) · PubMed · Cited by 751
Clinical diagnosis and staging of cholangiocarcinoma
Blechacz, B., Komuta, M., Roskams, T., & Gores, G. J. (2011) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2011.131 · Cited by 747
Okusaka, T., Nakachi, K., Fukutomi, A., Mizuno, N., Ohkawa, S., Funakoshi, A., Nagino, M., Kondo, S., Nagaoka, S., Funai, J., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605779 · Cited by 744
Identification of Targetable FGFR Gene Fusions in Diverse Cancers
Wu, Y.-M., Su, F., Kalyana-Sundaram, S., Khazanov, N., Ateeq, B., Cao, X., Lonigro, R. J., Vats, P., Wang, R., Lin, S.-F., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0050 · Cited by 744
Borger, D. R., Tanabe, K. K., Fan, K. C., Lopez, H. U., Fantin, V. R., Straley, K. S., Schenkein, D. P., Hezel, A. F., Ancukiewicz, M., Liebman, H. M., et al. (2012) · The Oncologist · doi:10.1634/theoncologist.2011-0386 · Cited by 728
Jiao, Y., Pawlik, T. M., Anders, R. A., Selaru, F. M., Streppel, M. M., Lucas, D. J., Niknafs, N., Guthrie, V. B., Maitra, A., Argani, P., et al. (2013) · Nature Genetics · doi:10.1038/ng.2813 · Cited by 684
Nagino, M., Ebata, T., Yokoyama, Y., Igami, T., Sugawara, G., Takahashi, Y., & Nimura, Y. (2013) · Annals of Surgery · doi:10.1097/sla.0b013e3182708b57 · Cited by 656
Jaiswal, M., LaRusso, N. F., Burgart, L. J., & Gores, G. J. (2000) · PubMed · Cited by 653
Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study
Ortner, M. E. J., Caca, K., Berr, F., Liebetruth, J., Mansmann, U., Huster, D., Voderholzer, W., Schachschal, G., Mössner, J., & Lochs, H. (2003) · Gastroenterology · doi:10.1016/j.gastro.2003.07.015 · Cited by 608
CD13 is a therapeutic target in human liver cancer stem cells
Haraguchi, N., Ishii, H., Mimori, K., Tanaka, F., Ohkuma, M., Kim, H. M., Akita, H., Takiuchi, D., Hatano, H., Nagano, H., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42550 · Cited by 605
Darwish Murad, S., Kim, W. R., Harnois, D. M., Douglas, D. D., Burton, J., Kulik, L. M., Botha, J. F., Mezrich, J. D., Chapman, W. C., Schwartz, J. J., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.04.008 · Cited by 597
Sia, D., Hoshida, Y., Villanueva, A., Roayaie, S., Ferrer, J., Tabak, B., Peix, J., Sole, M., Tovar, V., Alsinet, C., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.01.001 · Cited by 575
Incidence and Risk Factors for Cholangiocarcinoma in Primary Sclerosing Cholangitis
Burak, K., Angulo, P., Pasha, T. M., Egan, K., Petz, J., & Lindor, K. D. (2004) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.04067.x · Cited by 557
Arai, Y., Totoki, Y., Hosoda, F., Shirota, T., Hama, N., Nakamura, H., Ojima, H., Furuta, K., Shimada, K., Okusaka, T., et al. (2014) · Hepatology · doi:10.1002/hep.26890 · Cited by 553
Andersen, J. B., Spee, B., Blechacz, B. R., Avital, I., Komuta, M., Barbour, A., Conner, E. A., Gillen, M. C., Roskams, T., Roberts, L. R., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.12.005 · Cited by 552
Self-citationWelzel, T. M., Graubard, B. I., Zeuzem, S., El-Serag, H. B., Davila, J. A., & McGlynn, K. A. (2011) · Hepatology · doi:10.1002/hep.24397 · Cited by 543
Navaneethan, U., Njei, B., Lourdusamy, V., Konjeti, R., Vargo, J. J., & Parsi, M. A. (2015) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2014.09.017 · Cited by 533
Cholangiocarcinomas can originate from hepatocytes in mice
Fan, B., Malato, Y., Calvisi, D. F., Naqvi, S., Razumilava, N., Ribback, S., Gores, G. J., Dombrowski, F., Evert, M., Chen, X., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63212 · Cited by 529
Self-citationCancer stem cells in the development of liver cancer
Yamashita, T., & Wang, X. W. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66024 · Cited by 525
ACG clinical guideline: primary sclerosing cholangitis
Lindor, K. D., Kowdley, K. V., & Harrison, E. M. (2015) · American Journal of Gastroenterology · doi:10.1038/ajg.2015.112 · Cited by 524
Palmer, W. C., & Patel, T. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.02.022 · Cited by 517
Chan-on, W., Nairismägi, M.-L., Ong, C. K., Lim, W. K., Dima, S., Pairojkul, C., Lim, K. H., McPherson, J. R., Cutcutache, I., Heng, H. L., et al. (2013) · Nature Genetics · doi:10.1038/ng.2806 · Cited by 497
Exome sequencing of liver fluke–associated cholangiocarcinoma
Ong, C. K., Subimerb, C., Pairojkul, C., Wongkham, S., Cutcutache, I., Yu, W., McPherson, J. R., Allen, G. E., Ng, C. C. Y., Wong, B. H., et al. (2012) · Nature Genetics · doi:10.1038/ng.2273 · Cited by 486
Intrahepatic Cholangiocarcinoma: expert consensus statement
Weber, S. M., Ribero, D., O'Reilly, E. M., Kokudo, N., Miyazaki, M., & Pawlik, T. M. (2015) · HPB · doi:10.1111/hpb.12441 · Cited by 472
Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancer
Saha, S. K., Parachoniak, C. A., Ghanta, K. S., Fitamant, J., Ross, K. N., Najem, M. S., Gurumurthy, S., Akbay, E. A., Sia, D., Cornella, H., et al. (2014) · Nature · doi:10.1038/nature13441 · Cited by 460
Inflammation and oncogenesis: a vicious connection
Grivennikov, S. I., & Karin, M. (2010) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.11.004 · Cited by 456
Ross, J. S., Wang, K., Gay, L., Al-Rohil, R., Rand, J. V., Jones, D. M., Lee, H. J., Sheehan, C. E., Otto, G. A., Palmer, G., et al. (2014) · The Oncologist · doi:10.1634/theoncologist.2013-0352 · Cited by 454
Romagnuolo, J., Bardou, M., Rahme, E., Joseph, L., Reinhold, C., & Barkun, A. N. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-7-200310070-00006 · Cited by 445
Mutational landscape of intrahepatic cholangiocarcinoma
Zou, S., Li, J., Zhou, H., Frech, C., Jiang, X., Chu, J. S. C., Zhao, X., Li, Y., Li, Q., Wang, H., et al. (2014) · Nature Communications · doi:10.1038/ncomms6696 · Cited by 434
Macrophage Plasticity and Polarization in Liver Homeostasis and Pathology
Sica, A., Invernizzi, P., & Mantovani, A. (2014) · Hepatology · doi:10.1002/hep.26754 · Cited by 422
Self-citationHilar cholangiocarcinoma: expert consensus statement
Mansour, J. C., Aloia, T. A., Crane, C. H., Heimbach, J. K., Nagino, M., & Vauthey, J.-N. (2015) · HPB · doi:10.1111/hpb.12450 · Cited by 414
Yoshikawa, D., Ojima, H., Iwasaki, M., Hiraoka, N., Kosuge, T., Kasai, S., Hirohashi, S., & Shibata, T. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604129 · Cited by 404
Wang, P., Dong, Q., Zhang, C., Kuan, P.-F., Liu, Y., Jeck, W. R., Andersen, J. B., Jiang, W., Savich, G. L., Tan, T.-X., et al. (2013) · Oncogene · doi:10.1038/onc.2012.315 · Cited by 399
Self-citationValle, J. W., Furuse, J., Jitlal, M., Beare, S., Mizuno, N., Wasan, H., Bridgewater, J., & Okusaka, T. (2014) · Annals of Oncology · doi:10.1093/annonc/mdt540 · Cited by 391
Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin
Komuta, M., Spee, B., Borght, S. V., De Vos, R., Verslype, C., Aerts, R., Yano, H., Suzuki, T., Matsuda, M., Fujii, H., et al. (2008) · Hepatology · doi:10.1002/hep.22238 · Cited by 363
Intrahepatic cholangiocarcinoma can arise from Notch-mediated conversion of hepatocytes
Sekiya, S., & Suzuki, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63065 · Cited by 348
Borad, M. J., Champion, M. D., Egan, J. B., Liang, W. S., Fonseca, R., Bryce, A. H., McCullough, A. E., Barrett, M. T., Hunt, K., Patel, M. D., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004135 · Cited by 344
Levy, C., Lymp, J., Angulo, P., Gores, G. J., Larusso, N., & Lindor, K. D. (2005) · Digestive Diseases and Sciences · doi:10.1007/s10620-005-2927-8 · Cited by 339
Second-line chemotherapy in advanced biliary cancer: a systematic review
Lamarca, A., Hubner, R. A., David Ryder, W., & Valle, J. W. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu162 · Cited by 339
Cholangiocarcinoma—controversies and challenges
Patel, T. (2011) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2011.20 · Cited by 337
Pathological classification of intrahepatic cholangiocarcinoma based on a new concept
Nakanuma, Y. (2010) · World Journal of Hepatology · doi:10.4254/wjh.v2.i12.419 · Cited by 335
[Primary sclerosing cholangitis].
Molina Jurado, M., Ferrer, J., & Gómez, N. (1984) · PubMed · Cited by 335
Komuta, M., Govaere, O., Vandecaveye, V., Akiba, J., Van Steenbergen, W., Verslype, C., Laleman, W., Pirenne, J., Aerts, R., Yano, H., et al. (2012) · Hepatology · doi:10.1002/hep.25595 · Cited by 333
Disrupting insulin-like growth factor signaling as a potential cancer therapy
Sachdev, D., & Yee, D. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0080 · Cited by 320
New staging system and a registry for perihilar cholangiocarcinoma
DeOliveira, M. L., Schulick, R. D., Nimura, Y., Rosen, C., Gores, G., Neuhaus, P., & Clavien, P.-A. (2011) · Hepatology · doi:10.1002/hep.24227 · Cited by 318
Disrupting Insulin-Like Growth Factor Signaling as a Potential Cancer Therapy
Sachdev, D., & Yee, D. (2008) · AACR Education book · doi:10.1158/aacr.edb-mct-06-0080 · Cited by 314
Sia, D., Losic, B., Moeini, A., Cabellos, L., Hao, K., Revill, K., Bonal, D., Miltiadous, O., Zhang, Z., Hoshida, Y., et al. (2015) · Nature Communications · doi:10.1038/ncomms7087 · Cited by 311
Cholangiocarcinoma in Primary Sclerosing Cholangitis: Risk Factors and Clinical Presentation
Boberg, K. M., Bergquist, A., Mitchell, S., Pares, A., Rosina, F., Broomé, U., Chapman, R., Fausa, O., Egeland, T., Rocca, G., et al. (2002) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655202760373434 · Cited by 311
Self-citationA prospective comparison of the diagnostic accuracy of ERCP, MRCP, CT, and EUS in biliary strictures
Rösch, T., Meining, A., Frühmorgen, S., Zillinger, C., Schusdziarra, V., Hellerhoff, K., Classen, M., & Helmberger, H. (2002) · Gastrointestinal Endoscopy · doi:10.1067/mge.2002.124206 · Cited by 311
Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin
Komuta, M., Borght, S. V., Kojiro, M., Aerts, R., & Roskams, T. (2007) · Cited by 301
Rimola, J., Forner, A., Reig, M., Vilana, R., de Lope, C. R., Ayuso, C., & Bruix, J. (2009) · Hepatology · doi:10.1002/hep.23071 · Cited by 298
Lau, S. K., Prakash, S., Geller, S. A., & Alsabeh, R. (2002) · Human Pathology · doi:10.1053/hupa.2002.130104 · Cited by 288
Heimbach, J. K., Sanchez, W., Rosen, C. B., & Gores, G. J. (2011) · HPB · doi:10.1111/j.1477-2574.2011.00298.x · Cited by 288
WNT signaling drives cholangiocarcinoma growth and can be pharmacologically inhibited
Boulter, L., Guest, R. V., Kendall, T. J., Wilson, D. H., Wojtacha, D., Robson, A. J., Ridgway, R. A., Samuel, K., Van Rooijen, N., Barry, S. T., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci76452 · Cited by 278
Self-citationSignificance of alternatively activated macrophages in patients with intrahepatic cholangiocarcinoma
Hasita, H., Komohara, Y., Okabe, H., Masuda, T., Ohnishi, K., Lei, X. F., Beppu, T., Baba, H., & Takeya, M. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01614.x · Cited by 275
Nuzzo, G. (2012) · Archives of Surgery · doi:10.1001/archsurg.2011.771 · Cited by 275
Keratin 19: a key role player in the invasion of human hepatocellular carcinomas
Govaere, O., Komuta, M., Berkers, J., Spee, B., Janssen, C., de Luca, F., Katoonizadeh, A., Wouters, J., van Kempen, L. C., Durnez, A., et al. (2014) · Gut · doi:10.1136/gutjnl-2012-304351 · Cited by 273
Liver transplantation for cholangiocarcinoma
Rosen, C. B., Heimbach, J. K., & Gores, G. J. (2010) · Transplant International · doi:10.1111/j.1432-2277.2010.01108.x · Cited by 271
Liau, J.-Y., Tsai, J.-H., Yuan, R.-H., Chang, C.-N., Lee, H.-J., & Jeng, Y.-M. (2014) · Modern Pathology · doi:10.1038/modpathol.2013.241 · Cited by 265
Cell-of-Origin of Cancer versus Cancer Stem Cells: Assays and Interpretations
Rycaj, K., & Tang, D. G. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0798 · Cited by 256
Fritscher-Ravens, A., Broering, D. C., Knoefel, W. T., Rogiers, X., Swain, P., Thonke, F., Bobrowski, C., Topalidis, T., & Soehendra, N. (2004) · American Journal of Gastroenterology · doi:10.1046/j.1572-0241.2003.04006.x · Cited by 254
Primary sclerosing cholangitis
Angulo, P., & Lindor, K. D. (1999) · Hepatology · doi:10.1002/hep.510300101 · Cited by 252
Kobayashi, M., Ikeda, K., Saitoh, S., Suzuki, F., Tsubota, A., Suzuki, Y., Arase, Y., Murashima, N., Chayama, K., & Kumada, H. (2000) · Cancer · doi:10.1002/1097-0142(20000601)88:11<2471::aid-cncr7>3.0.co;2-t · Cited by 247
Nathan, H., Pawlik, T. M., Wolfgang, C. L., Choti, M. A., Cameron, J. L., & Schulick, R. D. (2007) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-007-0282-0 · Cited by 245
SHIN, H.-R., LEE, C.-U., PARK, H.-J., SEOL, S.-Y., CHUNG, J.-M., CHOI, H.-C., AHN, Y.-O., & SHIGEMASTU, T. (1996) · International Journal of Epidemiology · doi:10.1093/ije/25.5.933 · Cited by 237
Nakazawa, K., Dobashi, Y., Suzuki, S., Fujii, H., Takeda, Y., & Ooi, A. (2005) · The Journal of Pathology · doi:10.1002/path.1779 · Cited by 234
Cancer stem cells: A contentious hypothesis now moving forward
O’Connor, M. L., Xiang, D., Shigdar, S., Macdonald, J., Li, Y., Wang, T., Pu, C., Wang, Z., Qiao, L., & Duan, W. (2014) · Cancer Letters · doi:10.1016/j.canlet.2013.11.012 · Cited by 233
Araki, K., Shimura, T., Suzuki, H., Tsutsumi, S., Wada, W., Yajima, T., Kobayahi, T., Kubo, N., & Kuwano, H. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.452 · Cited by 231
Nitric oxide–mediated inhibition of DNA repair potentiates oxidative DNA damage in cholangiocytes
Jaiswal, M., LaRusso, N. F., Shapiro, R. A., Billiar, T. R., & Gores, G. J. (2001) · Gastroenterology · doi:10.1053/gast.2001.20875 · Cited by 230
Isomoto, H., Kobayashi, S., Werneburg, N. W., Bronk, S. F., Guicciardi, M. E., Frank, D. A., & Gores, G. J. (2005) · Hepatology · doi:10.1002/hep.20966 · Cited by 227
Kobayashi, S., Werneburg, N. W., Bronk, S. F., Kaufmann, S. H., & Gores, G. J. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.010 · Cited by 226
Aishima, S., & Oda, Y. (2014) · Journal of Hepato-Biliary-Pancreatic Sciences · doi:10.1002/jhbp.154 · Cited by 224
HDAC6 Inhibition Restores Ciliary Expression and Decreases Tumor Growth
Gradilone, S. A., Radtke, B. N., Bogert, P. S., Huang, B. Q., Gajdos, G. B., & LaRusso, N. F. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2938 · Cited by 224
Wehbe, H., Henson, R., Meng, F., Mize-Berge, J., & Patel, T. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2130 · Cited by 224
Fujimoto, A., Furuta, M., Shiraishi, Y., Gotoh, K., Kawakami, Y., Arihiro, K., Nakamura, T., Ueno, M., Ariizumi, S.-I., Hai Nguyen, H., et al. (2015) · Nature Communications · doi:10.1038/ncomms7120 · Cited by 223
Li, L., Masica, D., Ishida, M., Tomuleasa, C., Umegaki, S., Kalloo, A. N., Georgiades, C., Singh, V. K., Khashab, M., Amateau, S., et al. (2014) · Hepatology · doi:10.1002/hep.27050 · Cited by 223
Carpino, G., Cardinale, V., Onori, P., Franchitto, A., Berloco, P. B., Rossi, M., Wang, Y., Semeraro, R., Anceschi, M., Brunelli, R., et al. (2012) · Journal of Anatomy · doi:10.1111/j.1469-7580.2011.01462.x · Cited by 221
Self-citationSustained IL-6/STAT-3 Signaling in Cholangiocarcinoma Cells Due to SOCS-3 Epigenetic Silencing
Isomoto, H., Mott, J. L., Kobayashi, S., Werneburg, N. W., Bronk, S. F., Haan, S., & Gores, G. J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.10.037 · Cited by 219
Taniai, M., Grambihler, A., Higuchi, H., Werneburg, N., Bronk, S. F., Farrugia, D. J., Kaufmann, S. H., & Gores, G. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2770 · Cited by 218
Hepatitis B Virus Infection and Intrahepatic Cholangiocarcinoma in Korea: A Case-Control Study
Lee, T. Y., Lee, S. S., Jung, S. W., Jeon, S. H., Yun, S.-C., Oh, H.-C., Kwon, S., Lee, S. K., Seo, D. W., Kim, M.-H., et al. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01796.x · Cited by 217
Desmoplastic stroma and cholangiocarcinoma: Clinical implications and therapeutic targeting
Sirica, A. E., & Gores, G. J. (2014) · Hepatology · doi:10.1002/hep.26762 · Cited by 217
Sabbatino, F., Villani, V., Yearley, J. H., Deshpande, V., Cai, L., Konstantinidis, I. T., Moon, C., Nota, S., Wang, Y., Al-Sukaini, A., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0715 · Cited by 216
Therapeutic Effects of Deleting Cancer-Associated Fibroblasts in Cholangiocarcinoma
Mertens, J. C., Fingas, C. D., Christensen, J. D., Smoot, R. L., Bronk, S. F., Werneburg, N. W., Gustafson, M. P., Dietz, A. B., Roberts, L. R., Sirica, A. E., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2130 · Cited by 212
Self-citationMultigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups
Simbolo, M., Fassan, M., Ruzzenente, A., Mafficini, A., Wood, L. D., Corbo, V., Melisi, D., Malleo, G., Vicentini, C., Malpeli, G., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.1943 · Cited by 209
Park, J., Tadlock, L., Gores, G. J., & Patel, T. (1999) · Hepatology · doi:10.1002/hep.510300522 · Cited by 206
The biliary tree—a reservoir of multipotent stem cells
Cardinale, V., Wang, Y., Carpino, G., Mendel, G., Alpini, G., Gaudio, E., Reid, L. M., & Alvaro, D. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.23 · Cited by 205
Self-citationIntra-hepatic and extra-hepatic cholangiocarcinoma: New insight into epidemiology and risk factors
Cardinale, V. (2010) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v2.i11.407 · Cited by 197
Self-citationSöreide, K., Körner, H., Havnen, J., & Söreide, J. A. (2004) · British Journal of Surgery · doi:10.1002/bjs.4815 · Cited by 193
Yoon, J., Higuchi, H., Werneburg, N. W., Kaufmann, S. H., & Gores, G. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.32410 · Cited by 193
Ibrahim, S. M., Mulcahy, M. F., Lewandowski, R. J., Sato, K. T., Ryu, R. K., Masterson, E. J., Newman, S. B., Benson, A., Omary, R. A., & Salem, R. (2008) · Cancer · doi:10.1002/cncr.23818 · Cited by 188
The role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinoma
Sirica, A. E. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2011.222 · Cited by 188
Benckert, C., Jonas, S., Cramer, T., von Marschall, Z., Schäfer, G., Peters, M., Wagner, K., Radke, C., Wiedenmann, B., Neuhaus, P., et al. (2003) · PubMed · Cited by 185
Liu, R., Zhao, R., Zhou, X., Liang, X., Campbell, D. J. W., Zhang, X., Zhang, L., Shi, R., Wang, G., Pandak, W. M., et al. (2014) · Hepatology · doi:10.1002/hep.27085 · Cited by 183
Boehm, L. M., Jayakrishnan, T. T., Miura, J. T., Zacharias, A. J., Johnston, F. M., Turaga, K. K., & Gamblin, T. C. (2015) · Journal of Surgical Oncology · doi:10.1002/jso.23781 · Cited by 181
Thuwajit (2009) · Oncology Reports · doi:10.3892/or_00000309 · Cited by 179
Cadamuro, M., Nardo, G., Indraccolo, S., Dall'Olmo, L., Sambado, L., Moserle, L., Franceschet, I., Colledan, M., Massani, M., Stecca, T., et al. (2013) · Hepatology · doi:10.1002/hep.26384 · Cited by 175
The emerging roles of microvesicles in liver diseases
Lemoinne, S., Thabut, D., Housset, C., Moreau, R., Valla, D., Boulanger, C. M., & Rautou, P.-E. (2014) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2014.7 · Cited by 172
Myofibroblast-derived PDGF-BB promotes hedgehog survival signaling in cholangiocarcinoma cells
Fingas, C. D., Bronk, S. F., Werneburg, N. W., Mott, J. L., Guicciardi, M. E., Cazanave, S. C., Mertens, J. C., Sirica, A. E., & Gores, G. J. (2010) · Hepatology · doi:10.1002/hep.24588 · Cited by 163
Self-citationMurad, S. D., Kim, W. R., Therneau, T. M., Gores, G. J., Rosen, C. B. B., Martenson, J. A., Alberts, S. R., & Heimbach, J. K. (2012) · Hepatology · doi:10.1002/hep.25629 · Cited by 162
Intra-arterial Therapy for Advanced Intrahepatic Cholangiocarcinoma: A Multi-institutional Analysis
Hyder, O. N., Marsh, J. W., Salem, R., Petre, E. N., Kalva, S. P., Liapi, E. A., Cosgrove, D., Neal, D., Kamel, I. R., Zhu, A. X., et al. (2013) · Annals of Surgical Oncology · doi:10.1245/s10434-013-3127-y · Cited by 159
Alvaro, D., Barbaro, B., Franchitto, A., Onori, P., Glaser, S. S., Alpini, G., Francis, H., Marucci, L., Sterpetti, P., Ginanni-Corradini, S., et al. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.050464 · Cited by 159
Self-citationHaga, H., Yan, I. K., Takahashi, K., Wood, J., Zubair, A., & Patel, T. (2015) · Journal of Extracellular Vesicles · doi:10.3402/jev.v4.24900 · Cited by 159
Sulpice, L., Rayar, M., Desille, M., Turlin, B., Fautrel, A., Boucher, É., Llamas‐Gutierrez, F., Meunier, B., Boudjéma, K., Clément, B., et al. (2013) · Hepatology · doi:10.1002/hep.26577 · Cited by 157
Bile acids activate EGF receptor via a TGF-α-dependent mechanism in human cholangiocyte cell lines
Werneburg, N. W., Yoon, J., Higuchi, H., & Gores, G. J. (2003) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00536.2002 · Cited by 157
Park, S.-Y., Kim, J. H., Yoon, H.-J., Lee, I., Yoon, H., & Kim, K.-P. (2011) · Clinical Radiology · doi:10.1016/j.crad.2010.11.002 · Cited by 152
Yamada, D., Ilyas, S. I., Razumilava, N., Bronk, S. F., Davila, J. I., Champion, M. D., Borad, M. J., Bezerra, J. A., Chen, X., & Gores, G. J. (2015) · Hepatology · doi:10.1002/hep.27687 · Cited by 145
Govaere, O., Wouters, J., Petz, M., Vandewynckel, Y., den Eynde, K. V., den broeck, A. V., Verhulst, S., Dollé, L., Gremeaux, L., Ceulemans, A., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.011 · Cited by 144
Cyclooxygenase-2 Promotes Human Cholangiocarcinoma Growth
Han, C. L., Leng, J., Demetris, A. J., & Wu, T. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1086 · Cited by 143
Herráez, E., Lozano, E., Macı́as, R. I. R., Vaquero, J., Bujanda, L., Bañales, J. M., Marı́n, J. J. G., & Briz, Ó. (2013) · Hepatology · doi:10.1002/hep.26425 · Cited by 143
Self-citationEGFR and HER2 expression in advanced biliary tract cancer
Harder, J., Waiz, O., Otto, F., Geißler, M., Olschewski, M., Weinhold, B., Blum, H. E., Schmitt-Graeff, A. H., & Opitz, O. G. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.4511 · Cited by 136
Terada, T., Nakanuma, Y., & Sirica, A. E. (1998) · Human Pathology · doi:10.1016/s0046-8177(98)90229-5 · Cited by 133
Clapéron, A., Mergey, M., Ho-Bouldoires, T. H. N., Vignjevic, D. M., Wendum, D., Chrétien, Y., Merabtene, F., Frazao, A., Paradis, V., Housset, C., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.03.033 · Cited by 132
Self-citationEnhanced epidermal growth factor receptor activation in human cholangiocarcinoma cells
Yoon, J., Gwak, G., Lee, H.-S., Bronk, S. F., Werneburg, N. W., & Gores, G. J. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.07.016 · Cited by 132
Bcl-2 is overexpressed and alters the threshold for apoptosis in a cholangiocarcinoma cell line
Harnois, D. M., Que, F. G., Celli, A., LaRusso, N. F., & Gores, G. J. (1997) · Hepatology · doi:10.1002/hep.510260413 · Cited by 130
Prognostic significance of overexpression of c-Met oncoprotein in cholangiocarcinoma
Miyamoto, M., Ojima, H., Iwasaki, M., Shimizu, H., Kokubu, A., Hiraoka, N., Kosuge, T., Yoshikawa, D., Kono, T., Furukawa, H., et al. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.199 · Cited by 129
Meng, F., Yamagiwa, Y., Ueno, Y., & Patel, T. C. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.10.030 · Cited by 128
Cardinale, V., Carpino, G., Reid, L., Gaudio, E., & Alvaro, D. (2012) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v4.i5.94 · Cited by 126
Self-citationCholangiocarcinoma: Molecular Pathways and Therapeutic Opportunities
Ilyas, S. I., Borad, M. J., Patel, T. C., & Gores, G. J. (2014) · Seminars in Liver Disease · doi:10.1055/s-0034-1394144 · Cited by 125
Gao, Q., Zhao, Y., Wang, X., Guo, W., Gao, S., Wei, L., Shi, J.-Y., Shi, G., Wang, Z., Zhang, Y., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.01.062 · Cited by 125
Andresen, K., Boberg, K. M., Vedeld, H. M., Honne, H., Jebsen, P., Hektoen, M., Wadsworth, C. A., Clausen, O. P. F., Lundin, K. E. A., Paulsen, V., et al. (2015) · Hepatology · doi:10.1002/hep.27707 · Cited by 124
Self-citationContrast enhanced CT-scan to diagnose intrahepatic cholangiocarcinoma in patients with cirrhosis
Iavarone, M. A., Piscaglia, F., Vavassori, S., Galassi, M., Sangiovanni, A., Venerandi, L., Forzenigo, L. V., Golfieri, R., Bolondi, L., & Colombo, M. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.02.013 · Cited by 124
Global Alterations of DNA Methylation in Cholangiocarcinoma Target the Wnt Signaling Pathway
Goeppert, B. F., Konermann, C., Schmidt, C. R., Bogatyrova, O., Geiselhart, L., Ernst, C., Gu, L., Becker, N., Zucknick, M., Mehrabi, A., et al. (2013) · Hepatology · doi:10.1002/hep.26721 · Cited by 123
Activation of biliary tree stem cells within peribiliary glands in primary sclerosing cholangitis
Carpino, G., Cardinale, V., Renzi, A., Hov, J. R., Berloco, P. B., Rossi, M., Karlsen, T. H., Alvaro, D., & Gaudio, E. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.06.018 · Cited by 123
Self-citationOhira, S., Sasaki, M., Harada, K., Sato, Y., Zen, Y., Isse, K., Kozaka, K., Ishikawa, A., Oda, K., Nimura, Y., et al. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.050204 · Cited by 120
Profiles of Cancer Stem Cell Subpopulations in Cholangiocarcinomas
Cardinale, V., Renzi, A., Carpino, G., Torrice, A., Bragazzi, M. C., Giuliante, F., Rose, A. M. D., Fraveto, A., Onori, P., Napoletano, C., et al. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.02.010 · Cited by 120
Self-citationZhang, Z., Lai, G., & Sirica, A. E. (2004) · Hepatology · doi:10.1002/hep.20143 · Cited by 120
Serotonin Metabolism Is Dysregulated in Cholangiocarcinoma, which Has Implications for Tumor Growth
Alpini, G. D., Invernizzi, P., Gaudio, E., Venter, J. K., Kopriva, S. E., Bernuzzi, F., Onori, P., Franchitto, A., Coufal, M., Frampton, G. A., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2133 · Cited by 120
Self-citationConstitutive Notch2 signaling induces hepatic tumors in mice
Dill, M. T., Tornillo, L., Fritzius, T., Terracciano, L., Semela, D., Bettler, B., Heim, M. H., & Tchorz, J. S. (2012) · Hepatology · doi:10.1002/hep.26165 · Cited by 115
Circulating CD14+CD16+ monocyte levels predict tissue invasive character of cholangiocarcinoma
Subimerb, C., Pinlaor, S., Lulitanond, V, Khuntikeo, N., Okada, S., McGrath, M. S., & Wongkham, S. (2010) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2010.04200.x · Cited by 113
Clapéron, A., Mergey, M., Aoudjehane, L., Ho-Bouldoires, T. H. N., Wendum, D., Prignon, A., Merabtene, F., Firrincieli, D., Desbois‐Mouthon, C., Scatton, O., et al. (2013) · Hepatology · doi:10.1002/hep.26585 · Cited by 112
Self-citationDifferential effects of targeting Notch receptors in a mouse model of liver cancer
Huntzicker, E. G., Hötzel, K., Choy, L., Che, L., Ross, J., Pau, G., Sharma, N., Siebel, C. W., Chen, X., & French, D. M. (2014) · Hepatology · doi:10.1002/hep.27566 · Cited by 111
Hepatic Stellate Cells May Relate to Progression of Intrahepatic Cholangiocarcinoma
Okabe, H., Beppu, T., Hayashi, H., Horino, K., Masuda, T., Komori, H., Ishikawa, S., Watanabe, M., Takamori, H., Iyama, K.-I., et al. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0568-4 · Cited by 111
Jimeno, A., Rubio‐Viqueira, B., Amador, M. L., Oppenheimer, D., Bouraoud, N., Kulesza, P., Sebastiani, V., Maitra, A., & Hidalgo, M. M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3586 · Cited by 110
Gwak, G., Yoon, J., Shin, C. M., Ahn, Y. J., Chung, J., Kim, Y. A., Kim, T., & Lee, H. S. (2005) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-005-0016-1 · Cited by 108
Zhang, J., Jiao, J., Cermelli, S., Muir, K., Jung, K. H., Zou, R., Rashid, A., Gagea, M., Zabludoff, S., Kalluri, R., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-1254 · Cited by 106
Drug sensitivity and drug resistance profiles of human intrahepatic cholangiocarcinoma cell lines
Tepsiri, N. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i18.2748 · Cited by 106
Borght, S. V., Komuta, M., Libbrecht, L. J., Katoonizadeh, A., Aerts, R., Dymarkowski, S., Verslype, C., Nevens, F., & Roskams, T. (2008) · Liver International · doi:10.1111/j.1478-3231.2008.01889.x · Cited by 105
Evrard, A., Cuq, P., Ciccolini, J., Vian, L., & Cano, J. P. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690589 · Cited by 105
Activated macrophages promote Wnt/β-catenin signaling in cholangiocarcinoma cells
Loilome, W., Bungkanjana, P., Techasen, A., Namwat, N., Yongvanit, P., Puapairoj, A., Khuntikeo, N., & Riggins, G. J. (2014) · Tumor Biology · doi:10.1007/s13277-014-1698-2 · Cited by 105
Ferrone, C. R., Ting, D. T., Shahid, M., Konstantinidis, I. T., Sabbatino, F., Goyal, L., Rice-Stitt, T. L., Mubeen, A., Arora, K. S., Bardeesey, N., et al. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-4247-8 · Cited by 103
Thelen, A., Scholz, A., Weichert, W., Wiedenmann, B., Neuhaus, P., Gessner, R. V., Benckert, C., & Jonas, S. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.674 · Cited by 101
Sato, Y., Harada, K., Itatsu, K., Ikeda, H., Kakuda, Y., Shimomura, S., Ren, X. S., Yoneda, N., Sasaki, M., & Nakanuma, Y. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090747 · Cited by 101
Opposing Actions of Endocannabinoids on Cholangiocarcinoma Growth
DeMorrow, S., Glaser, S. S., Francis, H., Venter, J. K., Vaculin, B. T., Vaculin, S., & Alpini, G. D. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608238200 · Cited by 100
Yoon, J., Canbay, A. E., Werneburg, N. W., Lee, S. P., & Gores, G. J. (2004) · Hepatology · doi:10.1002/hep.20125 · Cited by 100
Leptin Enhances Cholangiocarcinoma Cell Growth
Fava, G., Alpini, G. D., Rychlicki, C., Saccomanno, S., DeMorrow, S., Trozzi, L., Candelaresi, C., Venter, J. K., Sario, A. D., Marzioni, M., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6682 · Cited by 99
Self-citationGentilini, A., Rombouts, K., Galastri, S., Caligiuri, A., Mingarelli, E., Mello, T., Marra, F., Mantero, S., Roncalli, M. G., Invernizzi, P., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.06.012 · Cited by 98
Self-citationAsakawa, H., Koizumi, H., Koike, A., Takahashi, M., Wu, W., Iwase, H., Fukuda, M., & Ohta, T. (2010) · Breast Cancer Research · doi:10.1186/bcr2486 · Cited by 98
Clinical presentation, risk factors and staging systems of cholangiocarcinoma
Plentz, R. R., & Malek, N. P. (2015) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2015.02.001 · Cited by 98
Fava, G., Marucci, L., Glaser, S. S., Francis, H., Morrow, S. D., Benedetti, A., Alvaro, D., Venter, J. K., Meininger, C. J., Patel, T. C., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1470 · Cited by 98
Self-citationMartinez-Becerra, P., Vaquero, J., Romero, M. R., Lozano, E., Anadon, C. M., Macı́as, R. I. R., Serrano, M. A., Grañé-Boladeras, N., Muñoz‐Bellvís, L., Alvarez, L., et al. (2012) · Molecular Pharmaceutics · doi:10.1021/mp300028a · Cited by 96
Self-citationWannhoff, A., Hov, J. R., Folseraas, T., Rupp, C., Friedrich, K., Anmarkrud, J. A., Weiss, K. H., Sauer, P., Schirmacher, P., Boberg, K. M., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.08.005 · Cited by 94
Self-citationThe antecedents of biliary cancer: a primary care case–control study in the United Kingdom
Grainge, M. J., West, J., Solaymani–Dodaran, M., Aithal, G. P., & Card, T. R. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604765 · Cited by 94
The Expression of CD90/Thy-1 in Hepatocellular Carcinoma: An In Vivo and In Vitro Study
Sukowati, C. H. C., Anfuso, B., Torre, G., Francalanci, P., Crocè, L. S., & Tiribelli, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076830 · Cited by 94
Raggi, C., Invernizzi, P., & Andersen, J. B. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.09.007 · Cited by 93
Self-citationImpact of bile acids on the growth of human cholangiocarcinoma via FXR
Dai, J., Wang, H., Shi, Y. H., Dong, Y., Zhang, Y., & Wang, J. (2011) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-4-41 · Cited by 93
Mancino, A., Mancino, M. G., Glaser, S. S., Alpini, G. D., Bolognese, A., Izzo, L., Francis, H., Onori, P., Franchitto, A., Corradini, S. G., et al. (2008) · Digestive and Liver Disease · doi:10.1016/j.dld.2008.02.015 · Cited by 92
Self-citationLeggett, C. L., Gorospe, E. C., Murad, M. H., et al. (2012) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2012.03.002 · Cited by 92
Huang, L., Ramirez, J. C., Frampton, G. A., Golden, L. E., Quinn, M. A., Pae, H. Y., Horvat, D., Liang, L.-J., & DeMorrow, S. (2011) · Laboratory Investigation · doi:10.1038/labinvest.2011.62 · Cited by 89
Recent advances in the morphological and functional heterogeneity of the biliary epithelium
Han, Y., Glaser, S. S., Meng, F., Francis, H., Marzioni, M., McDaniel, K. M., Alvaro, D., Venter, J. K., Carpino, G., Onori, P., et al. (2013) · Experimental Biology and Medicine · doi:10.1177/1535370213489926 · Cited by 88
Self-citationTang, D., Nagano, H., Yamamoto, H., Wada, H., Nakamura, M., Kondo, M., Ôta, H., Yoshioka, S., Kato, H., Damdinsuren, B., et al. (2006) · Oncology Reports · doi:10.3892/or.15.3.525 · Cited by 88
Non-canonical Hedgehog signaling contributes to chemotaxis in cholangiocarcinoma
Razumilava, N., Gradilone, S. A., Smoot, R. L., Mertens, J. C., Bronk, S. F., Sirica, A. E., & Gores, G. J. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.11.005 · Cited by 88
Self-citationFabris, L., Cadamuro, M., Moserle, L., Dziura, J. D., Cong, X., Sambado, L., Nardo, G., Sonzogni, A., Colledan, M., Furlanetto, A., et al. (2011) · Hepatology · doi:10.1002/hep.24466 · Cited by 86
Alvaro, D., Bragazzi, M. C., Benedetti, A., Fabris, L., Fava, G., Invernizzi, P., Marzioni, M., Nuzzo, G., Strazzabosco, M., & Stroffolini, T. (2010) · Digestive and Liver Disease · doi:10.1016/j.dld.2010.05.002 · Cited by 85
Self-citationOkabe, H., Beppu, T., Ueda, M., Hayashi, H., Ishiko, T., Masuda, T., Otao, R., Horlad, H., Mima, K., Miyake, K., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27496 · Cited by 85
Tissue invasive macrophage density is correlated with prognosis in cholangiocarcinoma
Wongkham (2010) · Molecular Medicine Reports · doi:10.3892/mmr_00000303 · Cited by 85
Serum and bile biomarkers for cholangiocarcinoma
Alvaro, D. (2009) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e328325a894 · Cited by 84
Self-citationMeng, F., Han, Y., Staloch, D. A., Francis, T. C., Stokes, A., & Francis, H. (2011) · Hepatology · doi:10.1002/hep.24573 · Cited by 81
Yoon, H., Min, J., Lee, J. W., Kim, D., & Hong, H. J. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.11.130 · Cited by 81
Khatib, M. E., Kalnytska, A., Palagani, V., Kossatz-Boehlert, U., Manns, M. P., Malek, N. P., Wilkens, L., & Plentz, R. R. (2012) · Hepatology · doi:10.1002/hep.26147 · Cited by 81
Wlcek, K., Svoboda, M., Riha, J., et al. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.11.9.15176 · Cited by 80
Cocarcinogenic Effects of Intrahepatic Bile Acid Accumulation in Cholangiocarcinoma Development
Lozano, E., Sanchez‐Vicente, L., Monte, M. J., Herráez, E., Briz, Ó., Bañales, J. M., Marı́n, J. J. G., & Macı́as, R. I. R. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0503 · Cited by 80
Saborowski, A. L., Saborowski, M., Davare, M. A., Druker, B. J., Klimstra, D. S., & Lowe, S. W. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1311707110 · Cited by 78
Udali, S., Guarini, P., Moruzzi, S., Ruzzenente, A., Tammen, S. A., Guglielmi, A., Conci, S., Pattini, P., Olivieri, O., Corrocher, R., et al. (2015) · Hepatology · doi:10.1002/hep.27823 · Cited by 77
Surgical outcomes of 230 resected hilar cholangiocarcinoma in a single centre
Song, S. C., Choi, D. W., Kow, A. W. C., et al. (2012) · ANZ Journal of Surgery · doi:10.1111/j.1445-2197.2012.06195.x · Cited by 77
Cardinale, V., Wang, Y., Carpino, G., Reid, L. M., Gaudio, E., & Alvaro, D. (2012) · Hepatology · doi:10.1002/hep.25587 · Cited by 77
Self-citationThe therapeutic potential of agents targeting the type I insulin-like growth factor receptor
Zhang, H., & Yee, D. (2004) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.13.12.1569 · Cited by 75
Pharmacogenetics of the Organic Anion Transporting Polypeptide 1A2
Franke, R. M., Scherkenbach, L. A., & Sparreboom, A. (2009) · Pharmacogenomics · doi:10.2217/14622416.10.3.339 · Cited by 72
DeMorrow, S., Francis, H., Gaudio, E., Venter, J. K., Franchitto, A., Kopriva, S. E., Onori, P., Mancinelli, R., Frampton, G. A., Coufal, M., et al. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90455.2008 · Cited by 72
Self-citationFrancis, H., Onori, P., Gaudio, E., Franchitto, A., DeMorrow, S., Venter, J. K., Kopriva, S. E., Carpino, G., Mancinelli, R., White, M., et al. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0261 · Cited by 71
Self-citationIshimura, N., Bronk, S. F., & Gores, G. J. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00539.2003 · Cited by 70
Cited by
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
Banales, J. M., Marin, J. J. G., Lamarca, A., Rodrigues, P. M., Khan, S. A., Roberts, L. R., Cardinale, V., Carpino, G., Andersen, J. B., Braconi, C., et al. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0310-z · Cited by 2,411
Self-citationHuman primary liver cancer–derived organoid cultures for disease modeling and drug screening
Broutier, L., Mastrogiovanni, G., Verstegen, M. M., Francies, H. E., Gavarró, L. M., Bradshaw, C. R., Allen, G. E., Arnes-Benito, R., Sidorova, O., Gaspersz, M. P., et al. (2017) · Nature Medicine · doi:10.1038/nm.4438 · Cited by 1,471
“Thus, EpCAM, was highly expressed in all CCs (CC-1-3) and CHCs (CHC-1-2) tumouroids and corresponding patients’ tissues, but absent on HCCs tumouroids and tissues (Fig.”
InfluentialValle, J. W., Kelley, R. K., Nervi, B., Oh, D.-Y., & Zhu, A. X. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00153-7 · Cited by 1,043
Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma
Jusakul, A., Cutcutache, I., Yong, C. H., Lim, J. Q., Huang, M. N., Padmanabhan, N., Nellore, V., Kongpetch, S., Ng, A. W. T., Ng, L. M., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0368 · Cited by 969
Brindley, P. J., Bachini, M., Ilyas, S. I., Khan, S. A., Loukas, A., Sirica, A. E., Teh, B. T., Wongkham, S., & Gores, G. J. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00300-2 · Cited by 841
Metadata
- Authors
- Banales, J. M., Cardinale, V., Carpino, G., Marzioni, M., Andersen, J. B., Invernizzi, P., Lind, G. E., Folseraas, T., Forbes, S. J., Fouassier, L., Geier, A., Calvisi, D. F., Mertens, J. C., Trauner, M., Benedetti, A., Maroni, L., Vaquero, J., Macias, R. I. R., Raggi, C., Perugorria, M. J., Gaudio, E., Boberg, K. M., Marin, J. J. G., & Alvaro, D.
- Venue
- Nature Reviews Gastroenterology & Hepatology
- Published
- 2016-04-20
- Volume
- 13
- Issue
- 5
- Pages
- 261-280
- ISSN
- 1759-5045 (ISSN-L)
- 1759-5053
- OpenAlex
- W2337387091
- Cited by
- 1,376
- References
- 263
- FWCI
- 21.08
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.